CMMB: Chemomab Therapeutics Ltd - American Depositary Shares
今日CMMB汇率已更改2.73%。当日,交易品种以低点1.7701和高点1.9100进行交易。
关注Chemomab Therapeutics Ltd - American Depositary Shares动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
CMMB新闻
- Chemomab’s nebokitug shows disease-modifying potential in PSC trial
- Chemomab reports positive 48-week data for PSC drug nebokitug
- ALKS to Enter Sleep Disorder Market With $2.1B Avadel Acquisition
- Best Momentum Stocks to Buy for Oct. 23
- New Strong Buy Stocks for Oct. 23: MQ, GES and More
- SNY's Efdoralprin Alfa Meets Key Endpoints in Rare Disease Study
- Roche's Gazyva Secures FDA Nod for Label Expansion in Lupus Nephritis
- NVO's Rybelsus Gets FDA Nod to Reduce Heart Risk in Diabetes Patients
- ESPR Aims to Diversify With Rare Liver Disease Candidate, Stock Up
- NVO and LLY Stocks Slide as Trump Signals Price Cuts for GLP-1 Drugs
- Viatris Acquires Aculys Pharma to Expand Neurology Portfolio in Japan
- CORT Files MAA for Relacorilant in Platinum-Resistant Ovarian Cancer
- RCKT Stock Up as FDA Accepts Resubmitted BLA for Gene Therapy
- TVRD Stock Plunges 84% After Phase II Fibrosis Study Misses Key Goals
- Zoetis Gains CVMP Backing for Lenivia, Eyes EU Approval in Dog OA Pain
- TEVA Gets FDA Nod for Uzedy Label Expansion in Bipolar I Disorder
- CDTX Stock Up on FDA's Breakthrough Therapy Tag for CD388 in Influenza
- OVID Stock Soars 39% in a Month Following Upbeat Epilepsy Study Data
- KALA Stock Crashes 88% in a Month Following Eye Disorder Study Failure
- AstraZeneca's Baxdrostat Meets Goal in Resistant Hypertension Study
- MRK Expands Tulisokibart Program in Three New Inflammatory Diseases
- Oppenheimer raises Chemomab stock price target to $25 on M&A potential
- U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.30%
- Upcoming Stock Splits This Week (August 25 to August 29) – Stay Invested - TipRanks.com
常见问题解答
CMMB股票今天的价格是多少?
Chemomab Therapeutics Ltd - American Depositary Shares股票今天的定价为1.8800。它在1.7701 - 1.9100范围内交易,昨天的收盘价为1.8300,交易量达到81。CMMB的实时价格图表显示了这些更新。
Chemomab Therapeutics Ltd - American Depositary Shares股票是否支付股息?
Chemomab Therapeutics Ltd - American Depositary Shares目前的价值为1.8800。股息政策取决于公司,而投资者也会关注27.46%和USD。实时查看图表以跟踪CMMB走势。
如何购买CMMB股票?
您可以以1.8800的当前价格购买Chemomab Therapeutics Ltd - American Depositary Shares股票。订单通常设置在1.8800或1.8830附近,而81和-1.57%显示市场活动。立即关注CMMB的实时图表更新。
如何投资CMMB股票?
投资Chemomab Therapeutics Ltd - American Depositary Shares需要考虑年度范围1.3500 - 2.0000和当前价格1.8800。许多人在以1.8800或1.8830下订单之前,会比较4.44%和。实时查看CMMB价格图表,了解每日变化。
Chemomab Therapeutics Ltd - American Depositary Shares股票的最高价格是多少?
在过去一年中,Chemomab Therapeutics Ltd - American Depositary Shares的最高价格是2.0000。在1.3500 - 2.0000内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪Chemomab Therapeutics Ltd - American Depositary Shares的绩效。
Chemomab Therapeutics Ltd - American Depositary Shares股票的最低价格是多少?
Chemomab Therapeutics Ltd - American Depositary Shares(CMMB)的最低价格为1.3500。将其与当前的1.8800和1.3500 - 2.0000进行比较,可以发现潜在的长期切入点。观看CMMB在图表上的实时走势以获取更多详细信息。
CMMB股票是什么时候拆分的?
Chemomab Therapeutics Ltd - American Depositary Shares历史上曾经历过股票拆分。这些变化在公司行动后的、1.8300和27.46%中可见。
- 前一天收盘价
- 1.8300
- 开盘价
- 1.9100
- 卖价
- 1.8800
- 买价
- 1.8830
- 最低价
- 1.7701
- 最高价
- 1.9100
- 交易量
- 81
- 日变化
- 2.73%
- 月变化
- 4.44%
- 6个月变化
- 27.46%
- 年变化
- 27.46%